Neurodegenerative plasma biomarkers for prediction of hippocampal atrophy in older adults with suspected Alzheimer's disease in Kinshasa, Democratic Republic of Congo
Journal of Alzheimer’s Disease · 2025-09 · 107 (2) · 628-640
DOI: 10.1177/13872877251360697 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2025-09. Verfasst von Jean Ikanga und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation Medicine, Emory University School of Medicine, Atlanta, GA, USA. Hauptthemen laut MEDLINE: Hippocampus, Alzheimer Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Institute on Aging.
Themen: Gerontologische Pflege, Demenz
Abstract (Originalsprache)
Background
Hippocampal atrophy is a key feature of Alzheimer's disease (AD), but neuroimaging is often inaccessible in low-resource settings. Blood-based biomarkers such as amyloid-β (Aβ 42/40 ), phosphorylated tau-181 (p-tau181), neurofilament light (NfL), and glial fibrillary acidic protein (GFAP) may offer a practical alternative, though their utility in African populations remains understudied.
Objective
This study investigated the ability of plasma biomarkers of AD and AD-related dementias—Aβ 42/40 , p-tau181, NfL, and GFAP—to predict hippocampal atrophy in older adults in Kinshasa, Democratic Republic of Congo.
Methods
Eighty-five adults aged over 65 (40 healthy; 45 suspected AD) were recruited. Core AD (Aβ 42/40 , p-tau181) and non-specific (NfL, GFAP) biomarkers were analyzed. Hippocampal volumes were measured using MRI. Linear and logistic regressions assessed biomarker differences by age, sex, and neurological status, and predicted hippocampal atrophy.
Results
Elevated p-tau181 was associated with left hippocampal (LH) atrophy (p = 0.020), with 4.2-fold increased odds [OR = 4.2 (1.5–18.4)] of LH atrophy per standard deviation increase. The areas under the curve of plasma biomarkers without clinical covariates to discriminate LH, right hippocampal (RH), and total hippocampal (TH) atrophy ranged from 90%–94%, 76%–82%, and 85%–87%, respectively. Models including clinical covariates and biomarkers improved discrimination to 94%–96% (LH), 81%–84% (RH), and 88%–90% (TH).
Conclusions
Consistent with findings from other settings, core AD plasma biomarkers can effectively predict hippocampal atrophy in a Sub-Saharan African population, supporting their potential for scalable dementia screening where imaging is limited.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rehabilitation Medicine, Emory University School of Medicine, Atlanta, GA, USA.
- School of Medicine, Kinshasa, Department of Psychiatry, University of Kinshasa and Catholic University of Congo, Kinshasa, Democratic Republic of Congo.
- Department of Psychology, Mercer University, Atlanta, GA, USA.
- OneRehab, Dallas, TX, USA.
- School of Medicine, Department of Biomedical Informatics, Emory University, Atlanta, GA, USA.
- Department of Neurology, Kinshasa, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
ORCID-Profile: Jean Ikanga, Kharine Jean, Priscilla Medina, Saranya Sundaram Patel, Megan Schwinne, Emmanuel Epenge, Guy Gikelekele, Nathan Tshengele, Charlotte E Teunissen, Anthony Stringer, Julio C Rojas, Brandon Chan, Argentina Lario Lago, Alvaro Alonso
Förderung
- National Institute on Aging
Zitieren
APA
Ikanga, J., Jean, K., Medina, P., Patel, S. S., Schwinne, M., Epenge, E., Gikelekele, G., Tshengele, N., Kavugho, I., Mampunza, S., Mananga, L., Teunissen, C. E., Stringer, A., Rojas, J. C., Chan, B., Lago, A. L., Boxer, A. L., Jeromin, A., Hanseeuw, B., …, & Alonso, A. (2025). Neurodegenerative plasma biomarkers for prediction of hippocampal atrophy in older adults with suspected Alzheimer's disease in Kinshasa, Democratic Republic of Congo. Journal of Alzheimer’s Disease, 107(2), 628-640. https://doi.org/10.1177/13872877251360697
Vancouver
Ikanga J, Jean K, Medina P, Patel SS, Schwinne M, Epenge E, et al. Neurodegenerative plasma biomarkers for prediction of hippocampal atrophy in older adults with suspected Alzheimer's disease in Kinshasa, Democratic Republic of Congo. Journal of Alzheimer’s Disease. 2025;107(2):628-640. doi:10.1177/13872877251360697
BibTeX
@article{Ikanga2025,
author = {Ikanga, Jean and Jean, Kharine and Medina, Priscilla and Patel, Saranya Sundaram and Schwinne, Megan and Epenge, Emmanuel and Gikelekele, Guy and Tshengele, Nathan and Kavugho, Immaculee and Mampunza, Samuel and Mananga, Lelo and Teunissen, Charlotte E and Stringer, Anthony and Rojas, Julio C and Chan, Brandon and Lago, Argentina Lario and Boxer, Adam L and Jeromin, Andreas and Hanseeuw, Bernard and Gross, Alden L and Alonso, Alvaro},
title = {Neurodegenerative plasma biomarkers for prediction of hippocampal atrophy in older adults with suspected Alzheimer's disease in Kinshasa, Democratic Republic of Congo},
journal = {Journal of Alzheimer’s Disease},
year = {2025},
volume = {107},
number = {2},
pages = {628--640},
doi = {10.1177/13872877251360697}
}
EUVIMED